F. P. Worden
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: the MAESTRO study
.
Cancer.
2020
Contact
full name
F. P.
Worden
Quick Info
Collaboration
Co-author network
Map of science
